+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Premature Ejaculation Treatment Market Research Report by Drug Type, Type, Dosage Form, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4968711
  • Report
  • April 2022
  • Region: Global
  • 214 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Akorn Pharmaceuticals
  • Aytu BioScience
  • Eli Lilly and Company
  • Futura Medical PLC
  • Hetero Healthcare Ltd
  • Menarini Group
The Global Premature Ejaculation Treatment Market size was estimated at USD 2,931.87 million in 2021, USD 3,211.16 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.70% to reach USD 5,110.43 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Premature Ejaculation Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Type, the market was studied across Dapoxetine, Phosphodiesterase Type 5 (PDE5) Inhibitors, Selective Serotonin Reuptake Inhibitors (SSRIs), Topical Anesthetics, and Zertane.
  • Based on Type, the market was studied across Oral Therapies and Topical Therapies. The Oral Therapies is further studied across Nonselective Serotonin Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor.
  • Based on Dosage Form, the market was studied across Pills and Spray.
  • Based on Distribution Channel, the market was studied across Hospitals, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Premature Ejaculation Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Premature Ejaculation Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Premature Ejaculation Treatment Market, including Absorption Pharmaceuticals LLC, Akorn Pharmaceuticals, Allergan, Inc, Ampio Pharmaceuticals, Inc., Aytu BioScience, Bayer AG, Dong-A Pharmaceutical Co., Ltd, Eli Lilly and Company, Emcure Pharmaceuticals, Furiex Pharmaceuticals, Inc., Futura Medical PLC, GlaxoSmithKline plc, Hetero Healthcare Ltd, Innovus Pharmaceuticals, Janssen Pharmaceutica N. V, lpha Digital Health Pvt. Ltd, Menarini Group, NeuroHealing Pharmaceuticals, NeuroHealing Pharmaceuticals Inc., Pfizer Inc, Plethora Solutions Holdings Plc, Regent Pacific Group Limited, Veru Inc., WHOLESOME MEDTECH PRIVATE LIMITED, and zr pharma& GmbH.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Premature Ejaculation Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Premature Ejaculation Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Premature Ejaculation Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Premature Ejaculation Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Premature Ejaculation Treatment Market?
6. What is the market share of the leading vendors in the Global Premature Ejaculation Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Premature Ejaculation Treatment Market?
Frequently Asked Questions about the Global Premature Ejaculation Treatment Market

What is the estimated value of the Global Premature Ejaculation Treatment Market?

The Global Premature Ejaculation Treatment Market was estimated to be valued at $2931.9 Million in 2021.

What is the growth rate of the Global Premature Ejaculation Treatment Market?

The growth rate of the Global Premature Ejaculation Treatment Market is 9.7%, with an estimated value of $5110.4 Million by 2027.

What is the forecasted size of the Global Premature Ejaculation Treatment Market?

The Global Premature Ejaculation Treatment Market is estimated to be worth $5110.4 Million by 2027.

Who are the key companies in the Global Premature Ejaculation Treatment Market?

Key companies in the Global Premature Ejaculation Treatment Market include Absorption Pharmaceuticals LLC, Akorn Pharmaceuticals, Allergan, Inc, Ampio Pharmaceuticals, Inc., Aytu BioScience, Bayer AG, Dong, A Pharmaceutical Co., Ltd and Emcure Pharmaceuticals.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Akorn Pharmaceuticals
  • Aytu BioScience
  • Eli Lilly and Company
  • Futura Medical PLC
  • Hetero Healthcare Ltd
  • Menarini Group

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Raising awareness of premature ejaculation
5.1.1.2. Growing focus of companies in developing sales network to increase sales
5.1.1.3. Increasing prevalence of premature ejaculation
5.1.2. Restraints
5.1.2.1. Side effects associated with the premature ejaculation treatment
5.1.3. Opportunities
5.1.3.1. Rising research & development of drugs for treatment
5.1.3.2. Increasing strategic collaborations for development of new diagnostic tools
5.1.4. Challenges
5.1.4.1. Launch of alternative treatment methods for premature ejaculation
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Premature Ejaculation Treatment Market, by Drug Type
6.1. Introduction
6.2. Dapoxetine
6.3. Phosphodiesterase Type 5 (PDE5) Inhibitors
6.4. Selective Serotonin Reuptake Inhibitors (SSRIs)
6.5. Topical Anesthetics
6.6. Zertane
7. Premature Ejaculation Treatment Market, by Type
7.1. Introduction
7.2. Oral Therapies
7.2.1. Nonselective Serotonin Reuptake Inhibitor
7.2.2. Selective Serotonin Reuptake Inhibitor
7.3. Topical Therapies
8. Premature Ejaculation Treatment Market, by Dosage Form
8.1. Introduction
8.2. Pills
8.3. Spray
9. Premature Ejaculation Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Hospitals
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Premature Ejaculation Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Premature Ejaculation Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Premature Ejaculation Treatment Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Absorption Pharmaceuticals LLC
14.2. Akorn Pharmaceuticals
14.3. Allergan, Inc
14.4. Ampio Pharmaceuticals, Inc.
14.5. Aytu BioScience
14.6. Bayer AG
14.7. Dong-A Pharmaceutical Co., Ltd
14.8. Eli Lilly and Company
14.9. Emcure Pharmaceuticals
14.10. Furiex Pharmaceuticals, Inc.
14.11. Futura Medical PLC
14.12. GlaxoSmithKline plc
14.13. Hetero Healthcare Ltd
14.14. Innovus Pharmaceuticals
14.15. Janssen Pharmaceutica N. V
14.16. lpha Digital Health Pvt. Ltd
14.17. Menarini Group
14.18. NeuroHealing Pharmaceuticals
14.19. NeuroHealing Pharmaceuticals Inc.
14.20. Pfizer Inc
14.21. Plethora Solutions Holdings Plc
14.22. Regent Pacific Group Limited
14.23. Veru Inc.
14.24. WHOLESOME MEDTECH PRIVATE LIMITED
14.25. zr pharma& GmbH
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: DYNAMICS
FIGURE 2. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2027
FIGURE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS), 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS), BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 16. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2027
FIGURE 18. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (%)
FIGURE 27. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2027
FIGURE 29. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 34. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 36. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 41. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 42. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PREMATURE EJACULATION TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS), BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS), BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY REGION, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 68. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 73. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: SCORES
TABLE 108. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: BUSINESS STRATEGY
TABLE 109. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 110. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: RANKING
TABLE 111. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 112. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: MERGER & ACQUISITION
TABLE 113. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 114. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 115. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 116. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 117. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Absorption Pharmaceuticals LLC
  • Akorn Pharmaceuticals
  • Allergan, Inc
  • Ampio Pharmaceuticals, Inc.
  • Aytu BioScience
  • Bayer AG
  • Dong-A Pharmaceutical Co., Ltd
  • Eli Lilly and Company
  • Emcure Pharmaceuticals
  • Furiex Pharmaceuticals, Inc.
  • Futura Medical PLC
  • GlaxoSmithKline plc
  • Hetero Healthcare Ltd
  • Innovus Pharmaceuticals
  • Janssen Pharmaceutica N. V
  • lpha Digital Health Pvt. Ltd
  • Menarini Group
  • NeuroHealing Pharmaceuticals
  • NeuroHealing Pharmaceuticals Inc.
  • Pfizer Inc
  • Plethora Solutions Holdings Plc
  • Regent Pacific Group Limited
  • Veru Inc.
  • WHOLESOME MEDTECH PRIVATE LIMITED
  • zr pharma& GmbH
Note: Product cover images may vary from those shown

Loading
LOADING...